OPTIMER PHARMACEUTICALS INC Increase (Decrease) in Accounts Receivable
OPTIMER PHARMACEUTICALS INC reported Increase (Decrease) in Accounts Receivable of $565.81 thousand for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2013-06-30 was $622.14K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2013-03-31 was -$56.33K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2012-12-31 was $878.92K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $927.74K.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2012 was $555.44K, a 91.54% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in accounts receivable for fiscal 2011 was $6.56M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2013-06-30 | $622.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $565.81K 10-Q · filed 2013-08-07 | $1.44M derived: sum of 3 quarters · filed 2013-08-07 | $2.37M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | -$56.33K 10-Q · filed 2013-05-10 | $822.59K derived: sum of 2 quarters · filed 2013-05-10 | $1.75M derived: sum of 3 quarters · filed 2013-05-10 | $1.71M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | $878.92K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.81M derived: sum of 2 quarters · filed 2013-03-18 | $1.77M derived: sum of 3 quarters · filed 2013-08-07 | $555.44K 10-K · filed 2013-03-18 |
| 2012-09-30 | $927.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $892.05K derived: sum of 2 quarters · filed 2013-08-07 | -$323.48K 10-Q · filed 2012-11-02 | -$1.76M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | -$35.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$1.25M 10-Q · filed 2013-08-07 | -$2.68M derived: sum of 3 quarters · filed 2013-08-07 | |
| 2012-03-31 | -$1.22M 10-Q · filed 2013-05-10 | -$2.65M derived: sum of 2 quarters · filed 2013-05-10 | ||
| 2011-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $6.56M 10-K · filed 2013-03-18 | ||
| 2011-09-30 | $8.00M 10-Q · filed 2012-11-02 | |||
| 2010-09-30 | -$29.29K 10-Q · filed 2011-11-03 |